Free Trial

TELA Bio (TELA) Competitors

TELA Bio logo
$2.85 +0.05 (+1.79%)
(As of 12/20/2024 05:31 PM ET)

TELA vs. NNOX, TCMD, DCTH, ZIMV, NPCE, RCEL, CVRX, SMTI, ZYXI, and LUNG

Should you be buying TELA Bio stock or one of its competitors? The main competitors of TELA Bio include Nano-X Imaging (NNOX), Tactile Systems Technology (TCMD), Delcath Systems (DCTH), ZimVie (ZIMV), NeuroPace (NPCE), AVITA Medical (RCEL), CVRx (CVRX), Sanara MedTech (SMTI), Zynex (ZYXI), and Pulmonx (LUNG). These companies are all part of the "medical equipment" industry.

TELA Bio vs.

TELA Bio (NASDAQ:TELA) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, media sentiment, risk, community ranking and profitability.

TELA Bio has a beta of 0.99, suggesting that its stock price is 1% less volatile than the S&P 500. Comparatively, Nano-X Imaging has a beta of 2.02, suggesting that its stock price is 102% more volatile than the S&P 500.

In the previous week, Nano-X Imaging's average media sentiment score of 0.05 beat TELA Bio's score of 0.00 indicating that Nano-X Imaging is being referred to more favorably in the news media.

Company Overall Sentiment
TELA Bio Neutral
Nano-X Imaging Neutral

TELA Bio received 30 more outperform votes than Nano-X Imaging when rated by MarketBeat users. Likewise, 74.68% of users gave TELA Bio an outperform vote while only 70.73% of users gave Nano-X Imaging an outperform vote.

CompanyUnderperformOutperform
TELA BioOutperform Votes
59
74.68%
Underperform Votes
20
25.32%
Nano-X ImagingOutperform Votes
29
70.73%
Underperform Votes
12
29.27%

94.3% of TELA Bio shares are held by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are held by institutional investors. 6.0% of TELA Bio shares are held by insiders. Comparatively, 7.7% of Nano-X Imaging shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

TELA Bio has a net margin of -60.49% compared to Nano-X Imaging's net margin of -465.38%. Nano-X Imaging's return on equity of -27.63% beat TELA Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
TELA Bio-60.49% -556.18% -63.13%
Nano-X Imaging -465.38%-27.63%-24.72%

TELA Bio has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TELA Bio$68.65M1.64-$46.66M-$1.69-1.69
Nano-X Imaging$9.90M39.45-$60.78M-$0.85-7.95

TELA Bio presently has a consensus target price of $9.25, suggesting a potential upside of 224.56%. Nano-X Imaging has a consensus target price of $12.00, suggesting a potential upside of 77.51%. Given TELA Bio's higher probable upside, research analysts plainly believe TELA Bio is more favorable than Nano-X Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TELA Bio
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00
Nano-X Imaging
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

TELA Bio beats Nano-X Imaging on 9 of the 16 factors compared between the two stocks.

Get TELA Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for TELA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TELA vs. The Competition

MetricTELA BioSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$112.26M$4.33B$5.10B$9.07B
Dividend YieldN/A41.46%4.90%4.21%
P/E Ratio-1.6925.3791.0817.15
Price / Sales1.6445.671,113.51116.81
Price / CashN/A43.4642.2637.86
Price / Book3.707.364.784.78
Net Income-$46.66M$13.64M$119.77M$225.60M
7 Day Performance2.89%-2.82%-1.87%-1.23%
1 Month Performance-1.38%0.54%11.46%3.07%
1 Year Performance-53.58%41.80%30.53%16.48%

TELA Bio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TELA
TELA Bio
2.9938 of 5 stars
$2.85
+1.8%
$9.25
+224.6%
-49.8%$112.26M$68.65M-1.69120High Trading Volume
NNOX
Nano-X Imaging
2.3594 of 5 stars
$7.41
+7.5%
$12.00
+61.9%
+2.9%$428.14M$10.68M-8.11190Positive News
TCMD
Tactile Systems Technology
3.5784 of 5 stars
$17.79
-0.7%
$23.00
+29.3%
+23.9%$426.96M$274.42M27.57980Analyst Upgrade
DCTH
Delcath Systems
2.8196 of 5 stars
$12.69
+4.8%
$21.50
+69.4%
+212.8%$405.75M$22.64M-9.6776Gap Down
ZIMV
ZimVie
2.3679 of 5 stars
$13.78
+0.4%
$18.33
+33.0%
-20.6%$380.33M$457.43M-1.052,600
NPCE
NeuroPace
3.7644 of 5 stars
$11.21
+1.6%
$14.60
+30.2%
+24.4%$334.60M$76.45M-11.03170Analyst Forecast
Positive News
RCEL
AVITA Medical
1.6504 of 5 stars
$12.48
+2.2%
$16.50
+32.2%
-5.3%$327.23M$50.14M-5.48130News Coverage
Positive News
CVRX
CVRx
3.7816 of 5 stars
$13.42
+4.6%
$16.67
+24.2%
-49.2%$325.62M$47.26M-4.75200Positive News
SMTI
Sanara MedTech
1.9969 of 5 stars
$34.00
-1.9%
$44.00
+29.4%
-14.5%$297.16M$64.99M-35.0060
ZYXI
Zynex
3.4977 of 5 stars
$8.40
+3.2%
$14.00
+66.7%
-21.1%$267.54M$184.32M54.271,100Positive News
LUNG
Pulmonx
2.6794 of 5 stars
$6.14
+0.7%
$12.75
+107.7%
-49.2%$242.46M$79.30M-4.15250

Related Companies and Tools


This page (NASDAQ:TELA) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners